News Sentiment

TBPH sentiment intelligence

Theravance Biopharma Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 57 Balanced news tone 57 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 16.93 Week of 10 Jul 2026
Weighted tone 57/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Deals and strategy

71/100 classification confidence.

Company focus 49

directly relevant articles

Source quality 3

high-authority source matches

Trend context Trend inactive

+0.0% over one week, +1.7% over four weeks, trend inactive, and materially above fair value.

Latest direct headline Positive

Theravance Biopharma Price Target Raised to $17.00/Share From $15.00 by HC Wainwright & Co.

Market Reaction

Balanced read

53/100 confidence

News tone and price action are not far from neutral.

Primary event Deals and strategy 71/100 classification
One-week reaction 0.0% Price digesting
Trend fit Trend inactive 1.7% over four weeks
Fair value 45.7% Materially above fair value

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 20
Neutral 34
Negative 3

Relevance

Why the article matched

Direct first
Direct company coverage 49
Industry context 8
Sector context 0

Sources

Coverage mix

Publishers
Market source 11
Stock Titan 9
TradingView 7
Finviz 3
PR Newswire 3
Moomoo 2
Investing.com 2
simplywall.st 2

Event Lens

What the news is about

Classified themes
Deals and strategy 18
Market update 17
Earnings 15
Balance sheet 4
Analyst action 2
Guidance 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-57 of 57
www.marketscreener.com Direct company coverage

Theravance Biopharma, Inc.(NasdaqGM:TBPH) added to Russell 2000 Value-Defensive Index

Theravance Biopharma, Inc. (NasdaqGM:TBPH) has been added to the Russell 2000 Value-Defensive Index. This news follows a series of recent announcements for the company, including its addition to the Russell 2000 Growth-Defensive Index, first-quarter earnings results, and various

Tone
Positive 77/100
Event
Earnings
Published
29 Jun 2026 02:40
Source
www.marketscreener.com
TradingView Direct company coverage

Price to sales forward of Theravance Biopharma, Inc. – NASDAQ:TBPH

This article focuses on the "Price to sales forward" financial metric for Theravance Biopharma, Inc. (NASDAQ:TBPH). It briefly presents this data within the context of the company's financial information on TradingView. The content primarily provides navigation and structural ele

Tone
Neutral 50/100
Event
Market update
Published
27 Jun 2026 22:10
Source
TradingView
TradingView Direct company coverage

Price to book forward of Theravance Biopharma, Inc. – NASDAQ:TBPH

This article provides the "Price to book forward" value for Theravance Biopharma, Inc. (NASDAQ: TBPH). It indicates a specific period and market data source, highlighting it as financial information for investors. The article is a snippet of financial data from TradingView, focus

Tone
Neutral 50/100
Event
Market update
Published
26 Jun 2026 22:39
Source
TradingView
TradingView Direct company coverage

Enterprise value to revenue forward of Theravance Biopharma, Inc. – NASDAQ:TBPH

This article provides financial data for Theravance Biopharma, Inc. (NASDAQ: TBPH), specifically its enterprise value to revenue forward metric. The content appears to be a snapshot from a financial platform like TradingView, displaying the company's ticker, market status, and a

Tone
Neutral 50/100
Event
Earnings
Published
26 Jun 2026 13:09
Source
TradingView
TradingView Direct company coverage

Theravance Biopharma Inc Actuals & Estimates (NASDAQ:TBPH)

This article provides an overview of Theravance Biopharma, Inc. (NASDAQ: TBPH) financial actuals, analyst estimates, and stock performance data. It covers current stock price, market capitalization, historical highs and lows, future earnings expectations, and key financial metric

Tone
Positive 72/100
Event
Earnings
Published
26 Jun 2026 08:10
Source
TradingView